Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0045 USD | -.--% |
|
-.--% | -35.71% |
Valuation
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Capitalization 1 | 24.29 | 21.23 |
Enterprise Value (EV) 1 | 24.33 | 21.28 |
P/E ratio | -4.83 x | -417 x |
Yield | - | - |
Capitalization / Revenue | 232 x | 135 x |
EV / Revenue | 233 x | 135 x |
EV / EBITDA | -6.68 x | -425 x |
EV / FCF | 16,731,846 x | 882,688,999 x |
FCF Yield | 0% | 0% |
Price to Book | -109 x | -77.5 x |
Nbr of stocks (in thousands) | 493,639 | 493,639 |
Reference price 2 | 0.0492 | 0.0430 |
Announcement Date | 29/06/22 | 29/06/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 0.1604 | 0.1045 | 0.1571 |
EBITDA 1 | 0.0104 | -3.644 | -0.0501 |
EBIT 1 | 0.005401 | -3.645 | -0.0507 |
Operating Margin | 3.37% | -3,487.29% | -32.27% |
Earnings before Tax (EBT) 1 | 0.005184 | -3.645 | -0.0509 |
Net income 1 | 0.005184 | -3.645 | -0.0509 |
Net margin | 3.23% | -3,487.4% | -32.42% |
EPS 2 | 0.000017 | -0.0102 | -0.000103 |
Free Cash Flow | - | 1.454 | 0.0241 |
FCF margin | - | 1,391.3% | 15.35% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 29/06/22 | 29/06/22 | 29/06/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | - | 0.04 | 0.05 |
Net Cash position 1 | 0.03 | - | - |
Leverage (Debt/EBITDA) | - | -0.0116 x | -1.03 x |
Free Cash Flow | - | 1.45 | 0.02 |
ROE (net income / shareholders' equity) | - | 3,093% | 20.5% |
ROA (Net income/ Total Assets) | - | -4,573% | -59.4% |
Assets 1 | - | 0.0797 | 0.0857 |
Book Value Per Share 2 | -0 | -0 | -0 |
Cash Flow per Share 2 | 0 | 0 | 0 |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 29/06/22 | 29/06/22 | 29/06/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- NVGT Stock
- Financials Novagant Corp.